Public Health England has published Surgical site infections in NHS hospitals in England 2014/15. This annual report covers surgical site infection (SSI) data collected by NHS hospitals and independent sector NHS treatment centres. Data includes information on the number of operations performed, data quality, benchmarks, trends and risk factors. SSIs are also recorded by surgical category for each NHS Trusts in England.
- A prevention bundle was implemented for orthopedic MRSA SSIs.
- The bundle reinforced contact precaution and AMP stewardship.
- The MRSA SSI rate correlated negatively with cefazolin AUD.
- Prolonged AMP may increase the risk of MRSA SSI.
- The bundle was associated with the decrease in the incidence of MRSA SSIs.
Full reference:Kawamura, H et al.A bundle that includes active surveillance, contact precaution for carriers, and cefazolin-based antimicrobial prophylaxis prevents methicillin-resistant Staphylococcus aureus infections in clean orthopedic surgery. American Journal of Infection Control. Available online 30 October 2015
Clostridium difficile is the most frequent cause of health care–associated diarrhea and is a significant cause of morbidity and mortality.
A multidisciplinary task force, with the goal of reduction of Clostridium difficile infection (CDI) rates was formed; they instituted multiple, comprehensive interventions, including education of health care providers, proper environmental cleaning of rooms with CDI patients, and reduction in the use of fluoroquinolones.
These interventions were successful in reducing rates of health care–associated Clostridium difficile infection in the hospital.
Full reference: Waqar, S et al. Multidisciplinary performance improvement team for reducing health care–associated Clostridium difficile infection. American Journal of Infection Control 2015 Nov 3 [Epub ahead of print]